381
Standard Follow-up Compared With Extended Follow-up in Treating Patients Who Have Undergone Stem Cell Transplantation for Cancer
Condition(s):CancerLast Updated:September 21, 2010Completed
Stage III Multiple Myeloma: 436 Clinical Trials, Page 39 of 44
Hide Studies Not Open or Pending
382
Acupuncture in Treating Mucositis-Related Pain Caused by Chemotherapy in Patients Undergoing Stem Cell Transplantation
Condition(s):CancerLast Updated:April 30, 2015Completed
383
Prevention of Graft-Versus-Host Disease in Patients Undergoing Bone Marrow Transplantation
Condition(s):CancerLast Updated:May 2, 2014Completed
384
Laboratory Assay in Determining Cancer Resistance in Patients With Metastatic Cancer and in Healthy Participants
Condition(s):CancerLast Updated:May 30, 2017Completed
385
A Study to Evaluate the Safety of bb2121 in Subjects With High Risk, Newly Diagnosed Multiple Myeloma (NDMM)
Condition(s):Multiple MyelomaLast Updated:March 9, 2023Active, not recruiting
386
A Study to Evaluate the Efficacy and Safety of CAEL-101 in Patients With Mayo Stage IIIa AL Amyloidosis
Condition(s):AL AmyloidosisLast Updated:May 23, 2023Recruiting
387
A Study to Evaluate the Efficacy and Safety of CAEL-101 in Patients With Mayo Stage IIIb AL Amyloidosis
Condition(s):AL AmyloidosisLast Updated:May 23, 2023Recruiting
388
Personalized NK Cell Therapy in CBT
Condition(s):Accelerated Phase Chronic Myelogenous Leukemia, BCR-ABL1 Positive; Acute Biphenotypic Leukemia; Acute Lymphoblastic Leukemia; Acute Lymphoblastic Leukemia in Remission; Acute Myeloid Leukemia With Myelodysplasia-Related Changes; Acute Myeloid Leukemia With Variant MLL Translocations; B Acute Lymphoblastic Leukemia With t(9;22)(q34.1;q11.2); BCR-ABL1; Chemotherapy-Related Leukemia; Chronic Myelomonocytic Leukemia; Chronic Phase Chronic Myelogenous Leukemia, BCR-ABL1 Positive; High Grade B-Cell Lymphoma With MYC and BCL2 or BCL6 Rearrangements; ISS Stage II Plasma Cell Myeloma; ISS Stage III Plasma Cell Myeloma; Myelodysplastic Syndrome; Myelodysplastic Syndrome With Excess Blasts; Myelodysplastic Syndrome With Gene Mutation; Myelodysplastic/Myeloproliferative Neoplasm; Previously Treated Myelodysplastic Syndrome; Recurrent Acute Myeloid Leukemia; Recurrent Adult Acute Myeloid Leukemia; Recurrent Hodgkin Lymphoma; Recurrent Non-Hodgkin Lymphoma; Refractory Acute Lymphoblastic Leukemia; Refractory Adult Acute Lymphoblastic Leukemia; Secondary Acute Myeloid Leukemia; Therapy-Related Myelodysplastic SyndromeLast Updated:January 19, 2023Recruiting
389
Collecting Blood Samples From Patients With and Without Cancer to Evaluate Tests for Early Cancer Detection
Condition(s):Acute Lymphoblastic Leukemia; Acute Myeloid Leukemia; Ann Arbor Stage I Lymphoma; Ann Arbor Stage II Lymphoma; Ann Arbor Stage III Lymphoma; Ann Arbor Stage IV Lymphoma; Chronic Lymphocytic Leukemia; Chronic Myeloid Leukemia; Gastroesophageal Junction Adenocarcinoma; Head and Neck Carcinoma; Hematopoietic and Lymphoid Cell Neoplasm; Invasive Breast Carcinoma; Kidney Carcinoma; Malignant Hepatobiliary Neoplasm; Malignant Solid Neoplasm; Melanoma; Muscle-Invasive Bladder Carcinoma; RISS Stage I Plasma Cell Myeloma; RISS Stage II Plasma Cell Myeloma; RISS Stage III Plasma Cell Myeloma; Sarcoma; Stage I Bladder Cancer AJCC v6 and v7; Stage I Breast Cancer AJCC v7; Stage I Colorectal Cancer AJCC v6 and v7; Stage I Esophageal Cancer AJCC V7; Stage I Gastric Cancer AJCC V7; Stage I Lung Cancer AJCC v7; Stage I Ovarian Cancer AJCC v6 and v7; Stage I Pancreatic Cancer AJCC v6 and v7; Stage I Prostate Cancer AJCC v7; Stage I Uterine Corpus Cancer AJCC v7; Stage II Bladder Cancer AJCC v6 and v7; Stage II Breast Cancer AJCC v6 and v7; Stage II Colorectal Cancer AJCC v7; Stage II Esophageal Cancer AJCC v7; Stage II Gastric Cancer AJCC v7; Stage II Lung Cancer AJCC v7; Stage II Ovarian Cancer AJCC v6 and v7; Stage II Pancreatic Cancer AJCC v6 and v7; Stage II Prostate Cancer AJCC v7; Stage II Uterine Corpus Cancer AJCC v7; Stage III Bladder Cancer AJCC v6 and v7; Stage III Breast Cancer AJCC v7; Stage III Colorectal Cancer AJCC v7; Stage III Esophageal Cancer AJCC v7; Stage III Gastric Cancer AJCC v7; Stage III Lung Cancer AJCC v7; Stage III Ovarian Cancer AJCC v6 and v7; Stage III Pancreatic Cancer AJCC v6 and v7; Stage III Prostate Cancer AJCC v7; Stage III Uterine Corpus Cancer AJCC v7; Stage IV Bladder Cancer AJCC v7; Stage IV Breast Cancer AJCC v6 and v7; Stage IV Colorectal Cancer AJCC v7; Stage IV Esophageal Cancer AJCC v7; Stage IV Gastric Cancer AJCC v7; Stage IV Lung Cancer AJCC v7; Stage IV Ovarian Cancer AJCC v6 and v7; Stage IV Pancreatic Cancer AJCC v6 and v7; Stage IV Prostate Cancer AJCC v7; Stage IV Uterine Corpus Cancer AJCC v7; Thyroid Gland CarcinomaLast Updated:March 17, 2023Recruiting
390
Donor Peripheral Blood Stem Cell Transplant in Treating Patients With Hematologic Malignancies
Condition(s):Acute Biphenotypic Leukemia; Acute Erythroid Leukemia in Remission; Acute Leukemia in Remission; Acute Lymphoblastic Leukemia in Remission; Acute Myeloid Leukaemia With Prior Myelodysplastic Syndrome; Acute Myeloid Leukemia in Remission; Acute Myeloid Leukemia With FLT3/ITD Mutation; Acute Myeloid Leukemia With Inv(3)(Q21Q26.2); RPN1-EVI1; Acute Myeloid Leukemia With Multilineage Dysplasia; Acute Myeloid Leukemia With t(6;9); Acute Undifferentiated Leukemia; Adult Acute Lymphoblastic Leukemia in Complete Remission; B Acute Lymphoblastic Leukemia With T(1;19)(Q23;P13.3); E2A-PBX1 (TCF3-PBX1); Ph+ ALL; Burkitt Lymphoma; Childhood Acute Lymphoblastic Leukemia in Complete Remission; DS Stage II Plasma Cell Myeloma; DS Stage III Plasma Cell Myeloma; Myelodysplastic Syndrome; Recurrent Anaplastic Large Cell Lymphoma; Blasts Under 5 Percent of Bone Marrow Nucleated Cells; Recurrent Follicular Lymphoma; Recurrent Hodgkin Lymphoma; Recurrent Mantle Cell Lymphoma; Recurrent Marginal Zone Lymphoma; Recurrent Plasma Cell Myeloma; Refractory Plasma Cell Myeloma; Secondary Acute Myeloid Leukemia; T Lymphoblastic Lymphoma; Hematopoietic Cell Transplant RecipientLast Updated:January 23, 2023Terminated